ID MMEL1_HUMAN Reviewed; 779 AA. AC Q495T6; B9DI79; Q495T7; Q495T8; Q5SZS6; Q96PH9; DT 05-SEP-2006, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 2. DT 27-MAR-2024, entry version 154. DE RecName: Full=Membrane metallo-endopeptidase-like 1; DE EC=3.4.24.11; DE AltName: Full=Membrane metallo-endopeptidase-like 2; DE AltName: Full=NEP2(m); DE AltName: Full=Neprilysin II; DE Short=NEPII; DE AltName: Full=Neprilysin-2; DE Short=NEP2; DE Short=NL2; DE Contains: DE RecName: Full=Membrane metallo-endopeptidase-like 1, soluble form; DE AltName: Full=Neprilysin-2 secreted; DE Short=NEP2(s); GN Name=MMEL1; Synonyms=MELL1, MMEL2, NEP2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=11560781; DOI=10.1089/104454901316976127; RA Bonvouloir N., Lemieux N., Crine P., Boileau G., DesGroseillers L.; RT "Molecular cloning, tissue distribution, and chromosomal localization of RT MMEL2, a gene coding for a novel human member of the neutral endopeptidase- RT 24.11 family."; RL DNA Cell Biol. 20:493-498(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT RP THR-518. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Metalloprotease involved in sperm function, possibly by CC modulating the processes of fertilization and early embryonic CC development. Degrades a broad variety of small peptides with a CC preference for peptides shorter than 3 kDa containing neutral bulky CC aliphatic or aromatic amino acid residues. Shares the same substrate CC specificity with MME and cleaves peptides at the same amide bond (By CC similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Preferential cleavage of polypeptides between hydrophobic CC residues, particularly with Phe or Tyr at P1'.; EC=3.4.24.11; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000250}; CC -!- ACTIVITY REGULATION: Inhibited by thiorphan and phosphoramidon. CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type II membrane protein. CC Secreted. Note=A secreted form produced by proteolytic cleavage also CC exists. {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q495T6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q495T6-2; Sequence=VSP_020288, VSP_020289; CC Name=3; CC IsoId=Q495T6-3; Sequence=VSP_020287; CC -!- TISSUE SPECIFICITY: Predominantly expressed in testis. Weakly expressed CC in brain, kidney and heart. {ECO:0000269|PubMed:11560781}. CC -!- PTM: N-glycosylated. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the peptidase M13 family. {ECO:0000255|PROSITE- CC ProRule:PRU01233, ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAI01028.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAI01031.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAL08942.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF336981; AAL08942.1; ALT_FRAME; mRNA. DR EMBL; AL139246; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL589746; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL831784; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471183; EAW56082.1; -; Genomic_DNA. DR EMBL; BC101027; AAI01028.2; ALT_INIT; mRNA. DR EMBL; BC101028; AAI01029.2; -; mRNA. DR EMBL; BC101029; AAI01030.1; -; mRNA. DR EMBL; BC101030; AAI01031.2; ALT_INIT; mRNA. DR CCDS; CCDS30569.2; -. [Q495T6-1] DR RefSeq; NP_258428.2; NM_033467.3. [Q495T6-1] DR RefSeq; XP_016857799.1; XM_017002310.1. DR AlphaFoldDB; Q495T6; -. DR SMR; Q495T6; -. DR BioGRID; 122609; 2. DR IntAct; Q495T6; 1. DR STRING; 9606.ENSP00000367668; -. DR BindingDB; Q495T6; -. DR ChEMBL; CHEMBL3638356; -. DR MEROPS; M13.008; -. DR GlyCosmos; Q495T6; 5 sites, No reported glycans. DR GlyGen; Q495T6; 5 sites. DR iPTMnet; Q495T6; -. DR PhosphoSitePlus; Q495T6; -. DR BioMuta; MMEL1; -. DR DMDM; 114150028; -. DR jPOST; Q495T6; -. DR MassIVE; Q495T6; -. DR PaxDb; 9606-ENSP00000367668; -. DR PeptideAtlas; Q495T6; -. DR ProteomicsDB; 61971; -. [Q495T6-1] DR ProteomicsDB; 61972; -. [Q495T6-2] DR ProteomicsDB; 61973; -. [Q495T6-3] DR Antibodypedia; 1624; 180 antibodies from 26 providers. DR DNASU; 79258; -. DR Ensembl; ENST00000378412.8; ENSP00000367668.3; ENSG00000142606.16. [Q495T6-1] DR Ensembl; ENST00000502556.5; ENSP00000422492.1; ENSG00000142606.16. [Q495T6-3] DR Ensembl; ENST00000504800.5; ENSP00000425477.1; ENSG00000142606.16. [Q495T6-2] DR Ensembl; ENST00000611357.4; ENSP00000484606.1; ENSG00000277131.4. [Q495T6-1] DR Ensembl; ENST00000621908.3; ENSP00000482173.1; ENSG00000277131.4. [Q495T6-3] DR Ensembl; ENST00000628503.2; ENSP00000486668.1; ENSG00000277131.4. [Q495T6-2] DR GeneID; 79258; -. DR KEGG; hsa:79258; -. DR MANE-Select; ENST00000378412.8; ENSP00000367668.3; NM_033467.4; NP_258428.2. DR UCSC; uc001ajy.3; human. [Q495T6-1] DR AGR; HGNC:14668; -. DR CTD; 79258; -. DR DisGeNET; 79258; -. DR GeneCards; MMEL1; -. DR HGNC; HGNC:14668; MMEL1. DR HPA; ENSG00000142606; Tissue enhanced (testis). DR MalaCards; MMEL1; -. DR MIM; 618104; gene. DR neXtProt; NX_Q495T6; -. DR OpenTargets; ENSG00000142606; -. DR Orphanet; 186; Primary biliary cholangitis. DR PharmGKB; PA30865; -. DR VEuPathDB; HostDB:ENSG00000142606; -. DR eggNOG; KOG3624; Eukaryota. DR GeneTree; ENSGT00940000157799; -. DR HOGENOM; CLU_006187_4_1_1; -. DR InParanoid; Q495T6; -. DR OMA; PVIERDW; -. DR OrthoDB; 202716at2759; -. DR PhylomeDB; Q495T6; -. DR TreeFam; TF315192; -. DR BRENDA; 3.4.24.B14; 2681. DR PathwayCommons; Q495T6; -. DR SignaLink; Q495T6; -. DR BioGRID-ORCS; 79258; 14 hits in 1150 CRISPR screens. DR ChiTaRS; MMEL1; human. DR GenomeRNAi; 79258; -. DR Pharos; Q495T6; Tchem. DR PRO; PR:Q495T6; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q495T6; Protein. DR Bgee; ENSG00000142606; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 91 other cell types or tissues. DR ExpressionAtlas; Q495T6; baseline and differential. DR GO; GO:0005615; C:extracellular space; IDA:ARUK-UCL. DR GO; GO:0016020; C:membrane; IDA:ARUK-UCL. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0004175; F:endopeptidase activity; IDA:ARUK-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central. DR GO; GO:0016485; P:protein processing; IBA:GO_Central. DR GO; GO:0006508; P:proteolysis; IDA:ARUK-UCL. DR CDD; cd08662; M13; 1. DR Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1. DR Gene3D; 1.10.1380.10; Neutral endopeptidase , domain2; 1. DR InterPro; IPR024079; MetalloPept_cat_dom_sf. DR InterPro; IPR000718; Peptidase_M13. DR InterPro; IPR018497; Peptidase_M13_C. DR InterPro; IPR042089; Peptidase_M13_dom_2. DR InterPro; IPR008753; Peptidase_M13_N. DR PANTHER; PTHR11733:SF141; MEMBRANE METALLO-ENDOPEPTIDASE-LIKE 1; 1. DR PANTHER; PTHR11733; ZINC METALLOPROTEASE FAMILY M13 NEPRILYSIN-RELATED; 1. DR Pfam; PF01431; Peptidase_M13; 1. DR Pfam; PF05649; Peptidase_M13_N; 1. DR PRINTS; PR00786; NEPRILYSIN. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1. DR PROSITE; PS51885; NEPRILYSIN; 1. DR PROSITE; PS00142; ZINC_PROTEASE; 1. DR Genevisible; Q495T6; HS. PE 2: Evidence at transcript level; KW Alternative splicing; Coiled coil; Disulfide bond; Glycoprotein; Hydrolase; KW Membrane; Metal-binding; Metalloprotease; Protease; Reference proteome; KW Secreted; Signal-anchor; Transmembrane; Transmembrane helix; Zinc. FT CHAIN 1..779 FT /note="Membrane metallo-endopeptidase-like 1" FT /id="PRO_0000248415" FT CHAIN 74..779 FT /note="Membrane metallo-endopeptidase-like 1, soluble form" FT /evidence="ECO:0000250" FT /id="PRO_0000248416" FT TOPO_DOM 1..27 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 28..48 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 49..779 FT /note="Lumenal" FT /evidence="ECO:0000255" FT DOMAIN 88..779 FT /note="Peptidase M13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT COILED 515..560 FT /evidence="ECO:0000255" FT ACT_SITE 614 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233, FT ECO:0000255|PROSITE-ProRule:PRU10095" FT ACT_SITE 680 FT /note="Proton donor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT BINDING 135 FT /ligand="a peptide" FT /ligand_id="ChEBI:CHEBI:60466" FT /ligand_note="substrate" FT /evidence="ECO:0000250" FT BINDING 613 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233, FT ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 617 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233, FT ECO:0000255|PROSITE-ProRule:PRU10095" FT BINDING 676 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT SITE 73..74 FT /note="Cleavage" FT /evidence="ECO:0000250" FT CARBOHYD 177 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 207 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 350 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 530 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 657 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 89..94 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT DISULFID 112..764 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT DISULFID 120..724 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT DISULFID 175..439 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT DISULFID 650..776 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01233" FT VAR_SEQ 159..315 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_020287" FT VAR_SEQ 583..611 FT /note="VFPAGILQPPFFSKEQPQALNFGGIGMVI -> AYSLSRPWGQYSLPGSSSP FT PSSARSSHRP (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_020288" FT VAR_SEQ 612..779 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_020289" FT VARIANT 518 FT /note="M -> T (in dbSNP:rs3748816)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_027348" FT CONFLICT 351 FT /note="W -> R (in Ref. 4; AAI01029)" FT /evidence="ECO:0000305" FT CONFLICT 489 FT /note="M -> I (in Ref. 4; AAI01031)" FT /evidence="ECO:0000305" SQ SEQUENCE 779 AA; 89367 MW; 08C41819F4E81CBD CRC64; MGKSEGPVGM VESAGRAGQK RPGFLEGGLL LLLLLVTAAL VALGVLYADR RGKQLPRLAS RLCFLQEERT FVKRKPRGIP EAQEVSEVCT TPGCVIAAAR ILQNMDPTTE PCDDFYQFAC GGWLRRHVIP ETNSRYSIFD VLRDELEVIL KAVLENSTAK DRPAVEKART LYRSCMNQSV IEKRGSQPLL DILEVVGGWP VAMDRWNETV GLEWELERQL ALMNSQFNRR VLIDLFIWND DQNSSRHIIY IDQPTLGMPS REYYFNGGSN RKVREAYLQF MVSVATLLRE DANLPRDSCL VQEDMVQVLE LETQLAKATV PQEERHDVIA LYHRMGLEEL QSQFGLKGFN WTLFIQTVLS SVKIKLLPDE EVVVYGIPYL QNLENIIDTY SARTIQNYLV WRLVLDRIGS LSQRFKDTRV NYRKALFGTM VEEVRWRECV GYVNSNMENA VGSLYVREAF PGDSKSMVRE LIDKVRTVFV ETLDELGWMD EESKKKAQEK AMSIREQIGH PDYILEEMNR RLDEEYSNLN FSEDLYFENS LQNLKVGAQR SLRKLREKVD PNLWIIGAAV VNAFYSPNRN QIVFPAGILQ PPFFSKEQPQ ALNFGGIGMV IGHEITHGFD DNGRNFDKNG NMMDWWSNFS TQHFREQSEC MIYQYGNYSW DLADEQNVNG FNTLGENIAD NGGVRQAYKA YLKWMAEGGK DQQLPGLDLT HEQLFFINYA QVWCGSYRPE FAIQSIKTDV HSPLKYRVLG SLQNLAAFAD TFHCARGTPM HPKERCRVW //